Healthcare - Biotechnology - NASDAQ - US
$ 1.105
-13.7 %
$ 38.6 M
Market Cap
-0.35
P/E
INCOME STATEMENT
0
REVENUE
-127 M
OPERATING INCOME
-117 M
NET INCOME
EFFICIENCY
Earnings Waterfall
RAPT Therapeutics, Inc.
| Revenue | 0 |
| Cost Of Revenue | 3.55 M |
| Gross Profit | -3.55 M |
| Operating Expenses | 127 M |
| Operating Income | -127 M |
| Other Expenses | -10.3 M |
| Net Income | -117 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 0 | 1.5 | 3.8 | 5.0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 3.6 | 2.8 | 1.0 | 0 | 1.3 | 1.2 | 1.4 |
| Gross Profit | (3.6) | (1.3) | 2.8 | 5.0 | (1.3) | (1.2) | (1.4) |
| OPERATING INCOME | |||||||
| Operating Expenses | 127.1 | 87.3 | 73.0 | 58.3 | 43.6 | 36.9 | 29.3 |
| Selling, General and Administrative Expenses | 26.1 | 20.2 | 16.0 | 12.8 | 8.7 | 5.2 | 3.7 |
| Research and Development Expenses | 101.0 | 67.1 | 57.0 | 45.5 | 34.9 | 31.8 | 25.6 |
| Operating Income | (127.1) | (85.8) | (69.2) | (53.2) | (43.6) | (36.9) | (29.3) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 0 | (1.0) | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 10.3 | 2.0 | 5 K | 1.3 | 1.3 | 0.8 | 0.2 |
| Pre-Tax Income | (116.8) | (83.8) | (69.2) | (51.9) | (42.3) | (36.1) | (29.1) |
| NET INCOME | |||||||
| Tax Provision | 0 | (2.0) | (1.0) | 1.0 | 0.7 | 0.8 | 0 |
| Net Income | (116.8) | (81.9) | (68.2) | (52.9) | (43.0) | (36.1) | (29.1) |
| EPS | 3.05 | 2.52 | 2.49 | 2.19 | 1.97 | 2.09 | 2.01 |